HB 69 amends Pennsylvania's Cancer Drug Repository Program to allow unused, unopened cancer prescription drugs to be redistributed to indigent patients through approved pharmacies. The bill updates definitions (e.g., clarifying "cancer drug" includes drugs treating cancer or its side effects), requires drugs to be in original sealed packaging with unexpired dates, and mandates the State Board of Pharmacy to maintain a list of approved participating pharmacies. It also adds requirements for annual reporting and establishes procedures for restocking and dispensing drugs while maintaining safety standards. This directly affects indigent cancer patients seeking affordable medication and pharmacies participating in the program.
SB 535 amends Pennsylvania's Osteopathic Medical Practice Act to clarify the role of genetic counselors. It adds a definition for "genetic test" (including DNA/RNA analysis and chromosome studies) and specifies that genetic counselors may order such tests, provide documentation, and coordinate care - but cannot diagnose, test, manage, or treat genetic conditions. The bill directly affects genetic counselors practicing within Pennsylvania's osteopathic medical framework. These changes aim to standardize terminology and practice boundaries without altering the scope of other medical professionals.
This bill amends Pennsylvania's Medical Practice Act to clarify the role of genetic counselors. It adds a definition for "genetic test" (covering DNA/RNA analysis, biochemical tests, and chromosome studies) and specifies that genetic counselors may order these tests, coordinate care, and document medical information for clients' records. Crucially, the bill explicitly states genetic counselors cannot diagnose, test for, manage, or treat genetic conditions. The changes directly affect licensed genetic counselors practicing in Pennsylvania, defining their scope within the state's medical licensing framework. The bill takes effect 60 days after enactment.
HB 1117 amends Pennsylvania's 1929 Administrative Code to redefine the Department of Drug and Alcohol Programs' responsibilities for addressing substance use disorders. The department must now develop a comprehensive State plan coordinating prevention, treatment, research, and education across all state agencies and local communities - including health, law enforcement, education, and workforce sectors - to avoid duplication. The plan requires annual review and updates, and mandates the department to provide assistance to local governments while collaborating with medical professionals on drug use guidelines. This change formalizes existing coordination efforts under a unified framework, directly affecting state agencies and local entities managing substance use disorder services.
This bill directs the Pennsylvania Department of Drug and Alcohol Programs to issue two-year licenses to healthcare providers that meet specific quality standards, rather than the standard one-year renewal. To qualify for this extended license, providers must maintain good standing, hold a current multiyear accreditation from a national organization, and agree to notify the department within 14 days if that accreditation lapses. In exchange for the two-year term, the department will conduct only one comprehensive inspection per period instead of annual visits, though it retains the authority to inspect immediately if complaints arise. The law takes effect 60 days after being signed.
This bill establishes a three-year pilot program to provide grants for treating veterans with traumatic brain injuries and post-traumatic stress disorder. The State Veterans' Commission will award $150,000 annually to nonprofit organizations, academic institutions, and healthcare providers selected from the eastern, central, and western regions of Pennsylvania. Recipients must use the funds to develop and evaluate treatment programs aimed at improving mental health outcomes and reducing suicide risk among veterans. The program is set to expire three years after it begins, and the state will submit annual reports to the legislature detailing how the grants were used and their effectiveness.
SB 730 amends Pennsylvania law regarding end-of-life medical decisions, affecting patients, their designated surrogates, and healthcare providers, including emergency medical services. The bill introduces and integrates "Pennsylvania orders for life-sustaining treatment" (POLST) into the existing framework, alongside advance health care directives and out-of-hospital do-not-resuscitate (OOH-DNR) orders. It updates definitions for various healthcare roles to align with current state law and modifies criminal penalties for actions like falsifying or interfering with these medical orders. Additionally, the bill clarifies the applicability of emergency medical services in situations without an OOH-DNR order and standardizes the issuance of OOH-DNR orders, bracelets, and necklaces by physicians.
HB 1460, the Health System Protection Act, requires health care entities (like hospitals and clinics) and certain investors (such as private equity firms) to obtain pre-approval from Pennsylvania's Department of Health and Attorney General before completing major transactions. This applies to sales of assets worth $10 million or more, ownership changes, or large financial distributions that could affect competition, costs, or access to care. The law prohibits transactions deemed "against the public interest," such as those reducing competition, raising prices, or limiting services in rural or low-income areas. Health care entities must either file a notification with a waiting period or get written approval before proceeding.
This bill establishes a new paid family and medical leave program in Pennsylvania, creating a fund to support workers who need time off for family care or medical reasons. It requires employers to contribute to the program and sets rules for how long employees can take leave, how much money they receive, and what situations qualify for benefits, including care for family members with serious health conditions or recovery from domestic violence. The Department of Labor and Industry will administer the program, handle claims, and enforce rules, while employees have the right to take legal action if their rights are violated. The legislation also includes provisions for self-employed individuals to opt into the program and establishes an advisory board to guide program development.
This bill allocates state funding to support the operation of Pennsylvania's professional licensure boards and the State Athletic Commission for the 2026-2027 fiscal year. It provides $68.4 million from the Professional Licensure Augmentation Account to the Department of State's Bureau of Professional and Occupational Affairs, along with separate restricted funds totaling approximately $13.5 million for the State Boards of Medicine, Osteopathic Medicine, Podiatry, and the State Athletic Commission. The legislation ensures these organizations have the necessary resources to carry out their licensing and regulatory functions without treating these funds as general government appropriations.
